FREENOME PRESENTS RESEARCH THAT HIGHLIGHTS THE SIGNIFICANCE OF DETECTING ADENOMAS IN ANY TEST THAT SCREENS FOR COLORECTAL CANCER
/PRNewswire/ -- Freenome, a privately held biotech company, will present research at the American Association for Cancer Research (AACR) Annual Meeting that...
Source: prnewswire.com